Ad
related to: gsk
Search results
CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development...
Morningstar· 3 hours ago(Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), today announced dosing of the first ...
GSK Plc ADR (GSK): Worth A Small Bite At $45.15 – Stocks Register
Stocks Register· 4 days agoGSK Plc ADR (NYSE:GSK) concluded the trading at $45.15 on Thursday, May 23 with a fall of -1.38% from its closing price on previous day. Taking a look at ...
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga via Yahoo Finance· 7 days agoGSK Plc (NYSE:GSK) has been reportedly sued by an independent Connecticut laboratory, Valisure,...
Q3 2024 EPS Estimates for GSK plc Boosted by Zacks Research (NYSE:GSK)
ETF DAILY NEWS· 5 days agoGSK plc (NYSE:GSK – Free Report) – Analysts at Zacks Research increased their Q3 2024 earnings estimates for shares of GSK in a note ...
The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals,GSK, PTC Therapeutics and Larimar...
Zacks via Yahoo Finance· 4 days agoEquity Research analysts discuss the latest news and events impacting stocks and the financial...
GSK says its experimental drug reduced asthma attacks with only two doses a year
Quartz· 7 days agoPeople suffering from a severe form of asthma could soon see their symptoms improve with a new...
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report...
Benzinga· 1 day agoWestern pharmaceutical companies and investors are driving a record number of licensing deals with...
US, European nations consider vaccinating workers exposed to bird flu
Reuters via Yahoo News· 1 day agoU.S officials last week said they were moving bulk vaccine from CSL Seqirus that closely matches the...
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
Benzinga via Yahoo Finance· 7 days agoTuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and...
Why GSK (GSK) is a Top Momentum Stock for the Long-Term
Zacks via Yahoo Finance· 5 days agoThis Score can pinpoint good times to build a position in a stock, using factors like one-week price...